Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation TCT 2025

TCT 712: Evaluating Antithrombotic Therapy Variations Post-Left Atrial Appendage Occlusion: A Retrospective TriNetX Study

Presenter: FNU Parul

October 27, 2025

Presentation TCT 2025

Antithrombotic Strategies after LAAC: What Are the Options?

Presenter: Philippe PM Garot

October 27, 2025

Presentation TCT 2025

TCT 1009: Antithrombotic Strategy in Patients With Multivessel or Left Main Coronary Disease: A Post-Hoc Analysis From the EPIC-CAD Trial

Presenter: Kyeong-Won Seo

October 27, 2025

Presentation TCT 2025

TCT 1002: Impact of Antithrombotic Therapy Modification: Post Hoc Analysis of the EPIC CAD Trial

Presenter: Seong-Bong Wee

October 27, 2025

Presentation TCT 2025

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

Presenter: Noah Tregobov

October 27, 2025

Presentation TCT 2025

TCT 1223: Trends and Outcomes of Antithrombotic Strategies for Valve-in-Valve Transcatheter Aortic Valve Replacement: The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

Presenter: Hiroki Andrew Ueyama

October 26, 2025

Presentation TCT 2025

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Presenter: Yuriko Hiruma

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Presenter: Usman Baber

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Choosing Your SAPT For The Long Haul

Presenter: Marco Valgimigli

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Intraprocedural Therapies - Limitless Choices

Presenter: John A. Bittl

October 26, 2025

Presentation TCT 2025

Antithrombotic Therapies in ACS: Pre-treatment - Underrated or Overused?

Presenter: Salvatore Brugaletta

October 26, 2025

$Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis$

News Daily News

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

Todd Neale

August 13, 2025

News Daily News

No Clear Risk of Dementia After TIA: Framingham Heart Study

L.A. McKeown

July 10, 2025

Podcast TCTMD Talking Points

The EPIC-CAD Trial

July 02, 2025

Presentation NY Valves 2025

Antithrombotic Strategies After LAAC: What Are the Options?

Presenter: Philippe PM Garot

June 26, 2025

News Conference News ESOC 2025

ASSET-IT: Tirofiban Boosts Outcomes After IV Thrombolysis for Acute Stroke

Todd Neale

May 27, 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2025

Caitlin E. Cox

April 30, 2025

News Conference News EHRA 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

Todd Neale

April 09, 2025

News Conference News ACC 2025

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

Michael O'Riordan

April 02, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

Advertisement

TCT 712: Evaluating Antithrombotic Therapy Variations Post-Left Atrial Appendage Occlusion: A Retrospective TriNetX Study

Antithrombotic Strategies after LAAC: What Are the Options?

TCT 1009: Antithrombotic Strategy in Patients With Multivessel or Left Main Coronary Disease: A Post-Hoc Analysis From the EPIC-CAD Trial

TCT 1002: Impact of Antithrombotic Therapy Modification: Post Hoc Analysis of the EPIC CAD Trial

TCT 757: Hypo-attenuated Leaflet Thickening and Response to Antithrombotic Strategy in TAVR Patients with Elevated Gradients

TCT 1223: Trends and Outcomes of Antithrombotic Strategies for Valve-in-Valve Transcatheter Aortic Valve Replacement: The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry

TCT 772: Optimal Antithrombotic Therapy in Patients with Peripheral Artery Disease: A Systematic Review and Network Meta-analysis of Randomized Clinical Trials

Antithrombotic Therapies in ACS: Atrial Fibrillation - Triple Therapy, Triple Threat!

Antithrombotic Therapies in ACS: Choosing Your SAPT For The Long Haul

Antithrombotic Therapies in ACS: Intraprocedural Therapies - Limitless Choices

Antithrombotic Therapies in ACS: Pre-treatment - Underrated or Overused?

Coronary Sinus Reducer ‘Promising’ for Refractory Angina: Meta-analysis

No Clear Risk of Dementia After TIA: Framingham Heart Study

The EPIC-CAD Trial

Antithrombotic Strategies After LAAC: What Are the Options?

ASSET-IT: Tirofiban Boosts Outcomes After IV Thrombolysis for Acute Stroke

TCTMD’s Top 10 Most Popular Stories for April 2025

SWISS-APERO at 3 Years: Hints of Differences Between Amulet, Watchman Emerge

RIVAWAR: Rivaroxaban as Safe and Effective as Warfarin for LV Thrombus in MI

What’s Going to Be Hot at ACC 2025?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content